Observational studyMedicine2025
The role of prophylactic iron utilization and nutrition to prevent iron deficiency in infancy: Prospective cohort study.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Incorporating iron-rich foods into the diet, adequate breast milk intake, and prophylaxis with iron preparations can prevent iron deficiency anemia (IDA) and iron deficiency (ID) in infancy. This study aimed to elucidate the effects of prophylactic iron preparations, adequate breast milk, and iron-rich supplementary food intake on preventing IDA and ID in infancy. This prospective cohort study included 204 children aged 6 to 24 months who were admitted to the general pediatric outpatient clinic. The patients were divided into groups with and without ID and those with and without IDA. The rates of correct prophylaxis use, adequate breast milk intake, and supplementary food intake were compared. In our study, the ID and IDA rates were 53.9% (n = 110) and 34.8% (n = 71). The rate of recommendation for iron prophylaxis in the 204 patients in our study was 95.1% (n = 194). In our study, the rate of prophylactic use among all patients was 66.7% (n = 136). However, the proportion of patients who correctly used prophylaxis in the entire group was 13.7% (n = 28). The most critical risk factor for developing ID and IDA was lack of prophylaxis (P = .001 and odd ratio: 8.115 for ID and odd ratio: 13.364 for IDA). Prophylaxis emerged as the most critical risk factor for the development of ID and IDA in children aged 6 to 24 months. However, the consumption of more iron-rich foods and breastfeeding for the 1st 6 months is a reliable protective measure against ID and IDA, providing reassurance and confidence in the prevention of these conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.